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Several studies demonstrate that, within the ventral medullary surface
(VMS), excitatory amino acids are necessary components of the neural
circuits involved in the tonic and reflex control of respiration and
circulation. In the present study we investigated the cardiorespiratory
effects of unilateral microinjections of the broad spectrum glutamate
antagonist kynurenic acid (2 nmol/200 nl) along the VMS of urethane-
anesthetized rats. Within the VMS only one region was responsive to
this drug. This area includes most of the intermediate respiratory area,
partially overlapping the rostral ventrolateral medulla (IA/RVL). When
microinjected into the IA/RVL, kynurenic acid produced a respiratory
depression, without changes in mean arterial pressure or heart rate.
The respiratory depression observed was characterized by a decrease
in ventilation, tidal volume and mean inspiratory flow and an increase
in respiratory frequency. Therefore, the observed respiratory depres-
sion was entirely due to a reduction in the inspiratory drive. Microin-
jections of vehicle (200 nl of saline) into this area produced no
significant changes in breathing pattern, blood pressure or heart rate.
Respiratory depression in response to the blockade of glutamatergic
receptors inside the rostral VMS suggests that neurons at this site have
an endogenous glutamatergic input controlling the respiratory cycle
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The ventral medullary surface (VMS) is
widely considered to be an important site for
the integration of many autonomic and so-
matic functions including the respiratory and
cardiovascular control (1,2). Within the VMS,
three areas essential for the respiratory activ-
ity (rostral, intermediate and caudal) (3) co-
exist with sites responsible for the genera-
tion and maintenance of the vasomotor tone
and arterial blood pressure regulation: the
rostral ventrolateral medulla (RVL), caudal
ventrolateral medulla (CVL) (4,5) and the
caudal pressor area (CPA) (6-8). The RVL
overlaps most of the intermediate area,
whereas CVL overlaps the caudal respira-
tory area. Although CPA stimulation pro-
duces a well-defined respiratory activation
(9), so far this response has not been related
to any particular respiratory area.
Although the localization of these respi-
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ratory and cardiovascular areas in the VMS
is well established, the neurotransmitters in-
volved in these circuits remain largely un-
known. Several studies indicate that excita-
tory amino acids are significant components
of the neural circuits involved in the genera-
tion and maintenance of the respiratory
rhythm and vasomotor tone (10,11). Topical
application to (12) or microinjections (9,13)
of L-glutamate into the ventrolateral medul-
lary surface elicit pronounced changes in
respiration and arterial blood pressure. In a
previous study (9) we demonstrated that, in
the rat, three different breathing patterns
could be elicited from four distinct sites
within the VMS. When applied to the RVL
or the CPA, L-glutamate produced increases
in ventilation, inspiratory drive and hyper-
tension. Within the CVL two respiratory
patterns were observed: microinjection into
the rostral half of the CVL produced respira-
tory depression, while in the caudal half
increases in minute ventilation and inspira-
tory drive were associated with bradypnea.
Whether all of these areas represent sites of
tonic respiratory activity remains undeter-
mined.
To further characterize the role of gluta-
matergic afferents present in the VMS in
respiratory control, in the present study we
investigated the effects of microinjections of
the broad spectrum glutamate antagonist
kynurenic acid on the breathing pattern, ar-
terial blood pressure and heart rate of anes-
thetized rats.
Experiments were performed on male
Wistar rats (N = 25) weighing 300 ± 6 g
anesthetized with urethane (1.2 g/kg, ip),
tracheotomized and placed in a closed cylin-
der-shaped body plethysmograph (80 mm
ID, 300 mm long) with openings at both ends
to allow the externalization of the head, ther-
mal probe, and arterial and venous catheters.
Respiratory flow was recorded with a pneu-
motachometer (Fleisch No. 0000) connected
to the plethysmograph. After amplification
and analog to digital conversion, the signal
was computer-processed to quantify the pa-
rameters of the respiratory pattern (ventila-
tion, V
.
E; tidal volume, VT; inspiratory time,
TI; expiratory time, TE; breathing frequency,
f; mean inspiratory flow, VT/TI). Mean arte-
rial pressure (MAP) and heart rate (HR)
were monitored continually throughout the
experiment using a Statham transducer (P23
Db) connected to the femoral artery, coupled
to a Beckman R-611 polygraph. The animals
were placed prone in a stereotaxic frame
(Stoelting) and temperature was maintained
at 37oC. Kynurenic acid (KA, 2 nmol/200 nl)
was unilaterally microinjected into the VMS
according to a method previously described
(8). This method consistently allowed injec-
tions to be placed inside the ventral surface.
Each animal received one to three microin-
jections, at least 2 mm apart, distributed at
random along the VMS. A new site was
tested only after the effect of a previous
microinjection had completely disappeared.
At the end of the experiments the last injec-
tion site was marked with 200 nl of 2%
Evan’s blue dye. The animals were sacri-
ficed with an overdose of urethane, and the
brainstem was removed and fixed in 10%
formaldehyde. Injection sites were identi-
fied and plotted on a schematic diagram.
Other sites tested in the experiment were
plotted according to their relative position
with respect to the site marked with the dye.
To further identify injection sites, the brain-
stem was also cut coronally into 40-µm thick
sections and stained with 1% neutral red.
Photomicrographs and schematic drawings
of typical injection sites obtained with this
method have been presented elsewhere (9).
The breath-by-breath respiratory pattern data
for each animal were interpolated at 15-s
intervals. All data are reported as means ±
SEM. Friedman’s analysis of variance was
used to test whether or not values changed
with time after glutamate microinjection, with
subsequent post hoc comparisons by
Dunnett’s test. The criterion for statistical
significance was P<0.05.
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The distribution of responsive sites was
systematically explored within the VMS by
examining respiratory responses to unilat-
eral microinjections of KA (2 nmol/200 nl)
at 74 points. The area explored extended
from 6 mm rostral to 2.5 mm caudal to the
calamus scriptorius (CS) and up to 4 mm
lateral to the midline. The area surveyed is
illustrated in Figure 1. Active respiratory
sites, i.e., sites where KA produced signifi-
cant changes in respiration, were found in
the VMS in an area lying 2.3 to 3.8 mm
rostral and 1.5 to 2.5 mm lateral to the CS
(Figure 1). The time course and percentile
changes of respiratory parameters are pre-
sented in Figure 2. Before KA, ventilation
was 113 ± 9.6 ml/min, tidal volume was 1.5
± 0.1 ml and VT/TI was 4.9 ± 0.6 ml/s (N = 9).
Sixty seconds after KA administration, ven-
tilation was decreased by 27 ± 4.2%, tidal
volume by 38 ± 4.1% and VT/TI by 32 ±
4.0%. Respiratory depression was accompa-
nied by a 19 ± 3.7% increase in respiratory
frequency (control = 81 ± 7.2 breaths/min).
Therefore, the observed respiratory depres-
sion was entirely due to reduction in inspira-
tory drive. Although a progressive reduction
in both inspiratory and expiratory times was
observed, these reductions did not reach lev-
els of statistical significance (Table 1, Figure
2). No significant changes in MAP or HR
were observed (basal: 101.3 ± 7.6 and 389 ±
0.1; 60 s after KA: 106.9 ± 2.3 mmHg and
390 ± 0.1 beats/min, respectively). Microin-
jection of vehicle (200 nl of saline) into this
area produced no significant changes in any
of the parameters analyzed.
Previously (9), using unilateral microin-
jections of L-glutamate, we have demon-
strated the presence of cardiorespiratory ac-
tive sites along a column in the VMS extend-
ing from the VI cranial nerve to the first
cervical nerves in the caudal medulla. The
results obtained in the present study demon-
strate that within the VMS only in the region
of the intermediate respiratory area overlap-





Figure 1 - The diagram repre-
sents the ventral medullary sur-
face of the rat summarizing re-
sults obtained from 74 microin-
jections in 25 animals. Filled
circles indicate sites where uni-
lateral microinjections of kynu-
renic acid produced decreases
in ventilation, tidal volume and
inspiratory drive concurrently
with tachypnea, whereas the
small open dots indicate sites
where no significant respiratory
changes were obtained. For
clarity all microinjections are
represented on the left side re-
gardless of the actual side of
application. C1 = First cervical
nerve, VI and XII = 6th and 12th
cranial nerve rootlets, respec-
tively.
Table 1 - Cardiorespiratory responses produced by unilateral microinjections of kynurenic acid
into the ventrolateral medulla.
V
.
E, Ventilation; VT, tidal volume; TI, inspiratory time; TE, expiratory time; f, breathing frequency;
VT/TI, mean inspiratory flow; MAP, mean arterial pressure; HR, heart rate; N, number of
injection points. All values are reported as means ± SEM. Responses to kynurenic acid are
reported as percent change in relation to the control value. N = 11. *P<0.05 compared to control
(Friedman's analysis of variance).
Time Control % Change
15 s 30 s 45 s 60 s
MAP (mmHg) 101.3 ± 7.6 +5.1 ± 2.3 +5.6 ± 2.3 +5.6 ± 2.3 +5.6 ± 2.3
HR (beats/min) 389 ± 0.1 +0.1 ± 0.1 +0.1 ± 0.1 +0.1 ± 0.1 +0.1 ± 0.1
f (breaths/min) 81 ± 7.2 +3.7 ± 1.2 +8.5 ± 1.4* +8.1 ± 2.0* +18.6 ± 3.7*
VT (ml) 1.5 ± 0.1 -15.5 ± 2.5* -23.1 ± 3.1* -31.0 ± 3.2* -37.8 ± 4.1*
V
.
E (ml/min) 113.4 ± 9.6 -11.9 ± 2.0* -17.2 ± 3.4* -24.9 ± 3.4* -26.7 ± 4.2*
TI (s) 0.32 ± 0.02 -5.6 ± 6.6 -13.1 ± 6.2 -10.1 ± 4.1 -10.1 ± 4.1
TE (s) 0.50 ± 0.06 -1.6 ± 4.8 -1.5 ± 5.7 -11.9 ± 4.9 -16.2 ± 5.8
VT/TI (ml/s) 4.9 ± 0.6 -6.8 ± 4.9 -13.9 ± 3.9* -25.9 ± 4.8* -32.2 ± 4.0*
RVL), unilateral microinjections of KA pro-
duced a reduction in ventilation without
changing blood pressure or heart rate. Taken
together, these data indicate that only in the
IA/RVL are tonically active glutamatergic
inputs required to control inspiratory drive
and respiratory cycle duration.
Previous studies (10) reported that in
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anesthetized vagotomized rats, bilateral mi-
croinjection of KA (45 mM) into an area
equivalent to the IA/RVL here described
produced a 42% reduction in phrenic nerve
activity and a 27% increase in frequency,
simultaneously with a 15-mmHg hypoten-
sion. Similar results were also obtained in
other species. In cats, bilateral microinjec-
tions of KA into the IA/RVL resulted in
reduction of VT and a rise in respiratory
frequency (14). This respiratory depression
was associated with a reduction in phrenic
nerve activity with a decrease in the respira-
tory cycle timing (15). Similarly to the re-
sults obtained here, in these studies KA pro-
duced minor or no alteration in mean arterial
pressure or heart rate. Chemical or electro-
lytic inactivation of neurons in this area re-
sulted in apnea and decreased CO2 sensitiv-
ity in cats (16) or rabbits (17).
All of these studies were restricted to the
IA/RVL area. Our study demonstrated that
in this area even unilateral blockade of gluta-
matergic afferents is capable of producing
significant reductions in ventilation. Con-
trarily, in caudal portions of the VMS (in-
cluding the caudal respiratory area overlap-
ping the caudal ventrolateral medulla and
the caudal pressor area) unilateral glutama-
tergic blockade was unable to modify respi-
ration, even though these areas are respon-
sive to glutamate stimulation (9).
The local circuitry and the synaptic
mechanisms underlying the IA/RVL control
of respiratory rithmogenesis remain largely
unknown. Neurons in this area are exten-
sively connected to both the dorsal and ven-
tral respiratory groups (18) and represent the
link between the generators of respiratory
rhythm and vasomotor tone (10). Recently
Smith et al. (19) suggested that neurons in
the pre-Böotzinger complex, an area par-
tially overlapping the IA/RVL region, re-
quire glutamatergic inputs to maintain the
membrane potential in the range for the in-
trinsic oscillations adequate for the sponta-
neous activity and the mutual excitatory in-
teractions present in these cells. The origin
of these glutamatergic afferents remains un-
known.
In conclusion, although several sites in-
volved in the regulation of inspiratory drive
and timing mechanisms can be stimulated by
L-glutamate within the VMS, glutamatergic


















































-5 0 15 30 45 60
Time (s)













Figure 2 - Time course of
changes (mean ± SEM, % of
control) in ventilation (V
.
E), tidal
volume (VT), respiratory fre-
quency (f), inspiratory time (TI),
expiratory time (TE) and mean in-
spiratory flow (VT/TI) elicited by
unilateral microinjection of kynu-
renic acid (2 nmol/200 nl) into
responsive sites of the ventro-
lateral medulla. *P<0.05 com-
pared to control (Friedman's a-
nalysis of variance).
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